ABXL
NONEAbacus Global Management Inc
Live · NYSE · May 9, Close
What's Moving ABXL Today?
No stock-specific AI insight has been generated for ABXL yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$26.03
Fundamentals
Trading
ABXL News
4 articles- Earnings Flash (ABX) Abacus Global Management, Inc. Posts Q1 Adjusted EPS $0.20 per Share, vs. FactSet Est of $0.21marketscreener.com·May 7, 2026
- Earnings Flash (ABX) Abacus Global Management, Inc. Reports Q1 Revenue $59.4M, vs. FactSet Est of $64.2Mmarketscreener.com·May 7, 2026
- Abacus Chairman and CEO to Speak at the Milken Institute Global Conference in Los AngelesGlobeNewswire Inc.·May 1, 2026
- Abacus Global Management, Inc. Investigated by the Portnoy Law FirmGlobeNewswire Inc.·Mar 26, 2026
All 4 articles loaded
Price Data
52-Week Range
$26.03
Fundamentals
Trading
About Abacus Global Management Inc
ABXL (Abraxas BioScience) is a biopharmaceutical company dedicated to advancing innovative therapies for serious medical conditions, focusing on areas with substantial unmet medical needs. The company's robust pipeline features proprietary drug candidates developed using cutting-edge technologies in drug discovery and development. Committed to scientific excellence and regulatory adherence, ABXL fosters collaboration with academic and industry stakeholders, enhancing its capability to deliver transformative treatments that aim to significantly improve patient outcomes in the healthcare landscape.